Navigation Links
Osteoarthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

Profiles of Commonly Used Products in the OA Therapeutics Market 52

5.2.1 Celebrex (celecoxib) 52

5.2.2 Cymbalta (duloxetine hydrochloride) 53

5.2.3 Hyalgan (sodium hyaluronate) 54

5.2.4 Nucynta (tapentadol) 55

5.2.5 Voltaren Gel (diclofenac sodium topical gel 1%) 56

5.3 Key Takeaway 57

6 OA Therapeutics Market: Pipeline Assessment 58

6.1 Overview 58

6.2 Strategic Pipeline Assessment 58

6.2.1 OA Therapeutics – Molecules in Pre-Registration 60

6.2.2 OA Therapeutics – Phase III Pipeline 60

6.2.3 OA Therapeutics – Phase II/III Pipeline 61

6.2.4 OA Therapeutics – Phase II Pipeline 61

6.2.5 OA Therapeutics – Phase I/II Pipeline 62

6.2.6 OA Therapeutics – Phase I Pipeline 62

6.2.7 OA Therapeutics – Preclinical Pipeline 63

6.2.8 OA Therapeutics – Discovery Pipeline 64

6.3 OA Pipeline by Mechanism of Action 65

6.4 OA Technology Trends Analytical Framework 67

6.5 OA Therapeutics – Promising Drugs under Clinical Development 69

6.6 Molecule Profile for Promising Drugs under Clinical Development 70

6.6.1 Cartistem 70

6.6.2 Civanex (civamide, zucapsaicin) 70

6.6.3 Strontium Chloride Hexahydrate (2PX) 71

6.6.4 Oral Salmon Calcitonin (SMC021) 72

6.6.5 BEMA Buprenorphine 72

6.6.6 IP 880 and IP 889 73

6.7 Key Takeaway 73

7 Osteoarthritis Therapeutics – Clinical Trials Mapping 74

7.1 Clinical Trials by Country (US, EU5 and Japan) 74

7.2 Clinical Trials by Phase 75

7.3 Clinical Trials by Trial Status 76

7.4 Prominent Sponsors 77

7.5 Top Companies Participating in OA Therapeutics Clinical Trials 80

8 Osteoarthritis Therapeutics: Strategic Assessment 82

8.1 Osteoarthritis Therapeutics: Implications for Future Market Competition 82

9 Osteoarthritis Therapeutics: Future Playe
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate) for Treatment of Osteoarthritis
2. Actress Jane Kaczmarek Teams Up With DePuy Orthopaedics to Launch Osteoarthritis Awareness and Education Program
3. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
4. Former NBA Star Allan Houston Joins "Apply Yourself!" Campaign to Raise Awareness of Osteoarthritis Hand and Knee Pain
5. The Disease Modifying Effect of Chondroitin Sulphate in Patients With Knee Osteoarthritis Has Been Confirmed by MRI
6. Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued
7. Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
8. Logical Therapeutics Initiates Enrollment in New Gastrointestinal Safety Study in Osteoarthritis Patients
9. Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis
10. Panel of Osteoarthritis Experts Develops Optimal Profile of Exogenous Hyaluronic Acid
11. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... SAN DIEGO, Aug. 1, 2014 Arena ... provided a corporate update and reported financial results ... "We have continued to see ... including a 43% quarter-over-quarter increase in estimated total ... the 10,000 mark," said Jack Lief, Arena,s President ...
(Date:7/31/2014)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; Sorrento) ... Chief Business Officer and Executive Vice President. Mr. Singh died ... "Sorrento is deeply saddened and shocked by the ... go to Amar,s family and friends," said Henry Ji ... Mr. Singh joined Sorrento in January 2014 from Synta ...
(Date:7/31/2014)... July 31, 2014 Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® Insulin Pump, today reported its financial results ... In comparing the second quarter of 2014 to the same ... $10.3 million from $5.5 million , t:slim Pump shipments ... In comparing six months ended June 30, 2014 to ...
Breaking Medicine Technology:Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11Sorrento Announces the Unexpected Death of its Chief Business Officer 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6
(Date:8/1/2014)... New York, New York (PRWEB) August 01, 2014 ... ( http://www.gynecaremorcellatorlawsuit.com/ ) on behalf of women who allegedly ... use of power morcellators in gynecological surgeries, Bernstein Liebhard ... decision to withdraw a number of power morcellators marketed ... to a report from The New York Times, some ...
(Date:8/1/2014)... and the benefits of a cancer diagnosis may improve ... a study conducted by a researcher at the University ... an expressive writing intervention is the writing instruction. Otherwise, ... events. Writing a journal can be therapeutic, but oftentimes ... it,s effective or not," said Qian Lu, assistant professor ...
(Date:8/1/2014)... DELRAY BEACH, FL (PRWEB) August 01, 2014 ... hosted the 2014 California NextGen User Symposium in San ... event was held at the JW Marriott Union Square ... to help practices get up to speed with ACA ... said earlier this month. The symposium provides attendees guidance ...
(Date:8/1/2014)... August 01, 2014 According to ... by Geography (Asia-Pacific, North America, Europe, & ROW), ... by Fuel Type (Gasoline & Diesel), by After-Treatment ... - Trends & Forecasts to 2019", defines and ... an analysis of major countries in all the ...
(Date:8/1/2014)... (BRONX, NY) Scientists at Albert Einstein ... that bacteria that aid in digestion help keep the ... journal Immunity , could yield new therapies for ... other disorders. , The research involved the intestinal microbiome, ... these microorganisms in promoting or preventing disease is a ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:'Normal' bacteria vital for keeping intestinal lining intact 2
... Study found higher levels of staph, E. coli in ... News) -- Could common bacterial infections cause some cases of sudden ... of a study in this week,s issue of The Lancet ... levels of Staphylococcus aureus and Escherichia coli ...
... 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... joined the company as Vice President, International ... the development and,execution of clinical and regulatory ... candidates. Dr. Clarke was most recently,Vice President, ...
... MATK ) announced today that it will be ... Medical Technology,Conference in New York. The conference is being ... Palace Hotel. Peter L. Buzy, CFO is scheduled to ... Time., A live audio webcast of Martek,s presentation ...
... Ltd.,(Nasdaq: EMITF ) ("EI" or the "Company") today ... Loss for the first quarter of 2008 amounted to ... of NIS 27.3 million,(approximately US$ 7.7 million) is attributable ... NIS 23.8 million (approximately US$ 6.7,million) is attributable to ...
... the continued presence of a doula an experienced non-medical ... beneficial effects for middle- and upper-class women in childbirth, even ... with them, according to a new study in the journal ... of 420 pregnant women in their third trimester were randomized ...
... A critical enzyme used to prepare a powerful ... better target the cells the natural product attacks, according ... the Journal of Biological Chemistry. , Building on their ... Boston College and the University of Wisconsin, Madison discovered ...
Cached Medicine News:Health News:Bacterial Infection May Boost SIDS Risk 2Health News:Bacterial Infection May Boost SIDS Risk 3Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 2Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 13Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2
... bring a new standard in the field of ... Labs. Made of medical grade silicone, these durable ... a high level of flexibility while maintaining correct ... available in varying stiffnesses. Lengths are determined by ...
... primary objective of the BioPro Toe implant ... will relieve pain and restore motion while ... undisturbed. The procedure used to implant the ... resection. , ,The design for the great ...
Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
... of Ad-Techs products, our Sphenoidal Electrodes are manufactured ... available in stainless steel or platinum and feature ... (70 mm) long, 21 gauge (0.83 mm) introducing ... as kits or sets. You can also choose ...
Medicine Products: